Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
lorvotuzumab mertansine
(IMGN901) /
AbbVie
Welcome,
Profile
Billing
Logout
55 Diseases
0 Trials
0 Trials
46 News
1
2
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Disease Category View
Disease View
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Carcinoma
Lung Neoplasms
Small Cell Lung Carcinoma
Blood Coagulation Disorders
Blood Protein Disorders
Bronchial Neoplasms
Carcinoma, Bronchogenic
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immunoproliferative Disorders
Lung Diseases
Neutropenia
Respiratory Tract Diseases
Respiratory Tract Neoplasms
Thoracic Neoplasms
Acute Lymphocytic Leukemia
Acute Non Lymphoblastic Leukemia
Adenocarcinoma
Adnexal Diseases
Blastic Plasmacytoid Dendritic Cell
Carcinoid Tumor
Carcinoma, Merkel Cell
Carcinoma, Neuroendocrine
Communicable Diseases
DNA Virus Infections
Dendritic Cell Tumor
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Infection
Leukemia
Lymphoproliferative Disorders
Merkel Cell Carcinoma
Multiple Myeloma
Neoplasms by Histologic Type
Neoplasms, Germ Cell and Embryonal
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue
Neoplasms, Plasma Cell
Neuroectodermal Tumors
Neuroendocrine Tumors
Neuroepithelioma
Ovarian Cancer
Ovarian Diseases
Ovarian Neoplasms
Paraproteinemias
Polyomavirus Infections
1
2
»
